Sign Out
Single doses of 800 mg Orlistat and multiple doses of up 400 mg three times a day for 15 days have been studied in normal weight and obese subjects without significant adverse findings. In addition, doses of 240 mg three times a day have been administered to obese patients for 6 months without significant increase of adverse findings. Orlistat overdose cases received during post-marketing reported either no adverse events or adverse events that are similar to those reported recommended dose.
If the patient has taken more than capsules from recommended dosage please contact the doctor immediately as the patient may need medical attention.
